Changes in HIV outcomes following depression care in a resource-limited setting: Results from a pilot study in Bamenda, Cameroon

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Gaynes, Bradley N ^a   Pence, Brian W ^b   Atashili, Julius ^c   O'Donnell, Julie K ^b   Njamnshi, Alfred K ^d   Tabenyang, Mbu Eyongetah ^e   Arrey, Charles Kefie ^e   Whetten, Rachel ^f   Whetten, Kathryn ^f   Ndumbe, Peter ^c,d  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b The University of North Carolina at Chapel Hill   (United States)

^c UNIVERSITY OF BUEA   (Cameroon)

^d UNIVERSITY OF YAOUNDÉ I   (Cameroon)

^e Bamenda Hospital   (Cameroon)

^f DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; EFAVIRENZ PLUS LAMIVUDINE PLUS ZIDOVUDINE; LAMIVUDINE PLUS NEVIRAPINE PLUS ZIDOVUDINE; LOPINAVIR PLUS RITONAVIR; ZIDOVUDINE; ANTIDEPRESSANT AGENT; ANTIRETROVIRUS AGENT;

ADAPTIVE BEHAVIOR; ADULT; ARTICLE; CAMEROON; CD4 LYMPHOCYTE COUNT; COPING BEHAVIOR; DEPRESSION; FEMALE; FOLLOW UP; HEALTH STATUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MEASUREMENT BASED CARE; MEDICATION COMPLIANCE; MENTAL HEALTH CARE; PATIENT HEALTH QUESTIONNAIRE; PILOT STUDY; REMISSION; SELF CONCEPT; SOCIOECONOMICS; TREATMENT OUTCOME; VIRUS INHIBITION; VIRUS LOAD; AGED; COMPLICATION; DRUG EFFECTS; EVIDENCE BASED PRACTICE; HIV INFECTIONS; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; ANTI-RETROVIRAL AGENTS; ANTIDEPRESSIVE AGENTS; CAMEROON; CD4 LYMPHOCYTE COUNT; DEPRESSION; EVIDENCE-BASED PRACTICE; FEMALE; HIV INFECTIONS; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; TREATMENT OUTCOME; VIRAL LOAD;

EID: 84949035156     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140001     Document Type: Article

References (34)

1. Breuer E, Myer L, Struthers H, Joska JA. HIV/AIDS and mental health research in sub-Saharan Africa: a systematic review. African Journal of AIDS Research. 2011/06/01; 10(2):101-122. doi: 10.2989/16085906.2011.593373 PMID: 25859733
2. Adewuya AO, Afolabi MO, Ola BA, Ogundele OA, Ajibare AO, Oladipo BF. Psychiatric disorders among the HIV-positive population in Nigeria: a control study. Journal of psychosomatic research. Aug 2007; 63(2):203-206. PMID: 17662758
3. Sebit MB, Tombe M, Siziya S, Balus S, Nkomo SD, Maramba P. Prevalence of HIV/AIDS and psychiatric disorders and their related risk factors among adults in Epworth, Zimbabwe. East Afr Med J. 2003; 80(10):503-512. PMID: 15250622
4. Freeman M, Nkomo N, Kafaar Z, Kelly K. Mental disorder in people living with HIV/Aids in South Africa. S Afr J Psychol. Sep 2008; 38(3):489-500.
5. Collins PY, Holman AR, Freeman MC, Patel V. What is the relevance of mental health to HIV/AIDS care and treatment programs in developing countries? A systematic review. AIDS (London, England). Aug 1 2006; 20(12):1571-1582.
6. Blashill AJ, Gordon JR, Safren SA. Depression longitudinally mediates the association of appearance concerns to ART non-adherence in HIV-infected individuals with a history of injection drug use. J Behav Med. Nov 22 2012.
7. Gonzalez JS, Psaros C, Batchelder A, Applebaum A, Newville H, Safren SA. Clinician-assessed depression and HAART adherence in HIV-infected individuals in methadone maintenance treatment. Ann Behav Med. Aug 2011; 42(1):120-126. doi: 10.1007/s12160-011-9268-y PMID: 21503833
8. Stein MD, Solomon DA, Herman DS, Anderson BJ, Miller I. Depression severity and drug injection HIV risk behaviors. Am J Psychiatry. Sep 2003; 160(9):1659-1662. PMID: 12944342
9. Yang X, Latkin C, Celentano D, Luo H. Prevalence and correlates of HIV risk behaviors among drug users in China. AIDS and behavior. Jan 2006; 10(1):71-81. PMID: 16323036
10. Wagner GJ, Ghosh-Dastidar B, Holloway IW, Kityo C, Mugyenyi P. Depression in the pathway of HIV antiretroviral effects on sexual risk behavior among patients in Uganda. AIDS and behavior. Oct 2012; 16(7):1862-1869. PMID: 21986868
11. Freeman M, Patel V, Collins PY, Bertolote J. Integrating mental health in global initiatives for HIV/AIDS. Br J Psychiatry doi: 10.1192/bjp.187.1.1 July 1, 2005; 187(1):1-3.
12. World Health Organization. Essential prevention and care interventions for adults and adolescents living with HIV in resource-limited settings. Geneva, Switzerland 2008.
13. World Health Organization. mhGAP: Mental Health Gap Action Programme: scaling up care for mental, neurological and substance use disorders. Geneva, Switzerland 2008.
14. Layous K, Chancellor J, Lyubomirsky S, Wang L, Doraiswamy PM. Delivering happiness: translating positive psychology intervention research for treating major and minor depressive disorders. J Altern Complement Med. Aug 2011; 17(8):675-683. doi: 10.1089/acm.2011.0139 PMID: 21721928
15. Pence BW, Gaynes BN, Atashil J, O'Donnell JK, Kats D, Whetten K, et al. Feasibility, Safety, Acceptability, and Preliminary Efficacy of Measurement-Based Care Depression Treatment for HIV Patients in Bamenda, Cameroon. AIDS & Behavior. (In press, 2014).
16. Adams JL, Gaynes BN, McGuinness T, Modi R, Willig J, Pence BW. Treating depression within the HIV "medical home": a guided algorithm for antidepressant management by HIV clinicians. AIDS Patient Care STDS. Nov 2012; 26(11):647-654. doi: 10.1089/apc.2012.0113 PMID: 23134559
17. Gaynes BN, Rush AJ, Trivedi MH, Wisniewski SR, Balasubramani GK, McGrath PJ, et al. Primary versus specialty care outcomes for depressed outpatients managed with measurement-based care: results from S.T.A.R. ∗D. J Gen Intern Med. May 2008; 23(5):551-560. doi: 10.1007/s11606-008-0522-3 PMID: 18247097
18. Gaynes BN, Pence BW, Atashili J, O'Donnell J, Kats D, Ndumbe PM. Prevalence and predictors of major depression in HIV-infected patients on antiretroviral therapy in Bamenda, a semi-urban center in Cameroon. PloS one. 2012; 7(7):e41699. doi: 10.1371/journal.pone.0041699 PMID: 22860006
19. Pence BW, Gaynes BN, Atashili J, O'Donnell JK, Tayong G, Kats D, et al. Validity of an intervieweradministered patient health questionnaire-9 to screen for depression in HIV-infected patients in Cameroon. J Affect Disord. Dec 20 2012; 143(1-3):208-213. doi: 10.1016/j.jad.2012.05.056 PMID: 22840467
20. Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. Journal of General Internal Medicine. 2001; 16(9):606-613. PMID: 11556941
21. Landis SE, Gaynes BN, Morrissey JP, Vinson N, Ellis AR, Domino ME. Generalist Care Managers for the Treatment of Depressed Medicaid Patients in North Carolina: A Pilot Study. BMC Family Practice. Mar 5 2007; 8(1):7.
22. Wisniewski SR, Rush AJ, Balasubramani GK, Trivedi MH, Nierenberg AA for the S.T.A.R. D Investigators. Self-Rated Global Measure of the Frequency, Intensity, and Burden of Side Effects. Journal of Psychiatric Practice. 2006; 12:71-79. PMID: 16728903
23. Amico KR, Fisher WA, Cornman DH, Shuper PA, Redding CG, Konkle-Parker DJ, et al. Visual analog scale of ART adherence: association with 3-day self-report and adherence barriers. Journal of acquired immune deficiency syndromes (1999). Aug 1 2006; 42(4):455-459.
24. Chesney MA, Ickovics JR, Chambers DB, Gifford AL, Neidig J, Zwickl B, et al. Self-reported adherence to antiretroviral medications among participants in HIV clinical trials: the AACTG adherence instruments. Patient Care Committee & Adherence Working Group of the Outcomes Committee of the Adult AIDS Clinical Trials Group (AACTG). AIDS care. Jun 2000; 12(3):255-266. PMID: 10928201
25. Dybek I, Bischof G, Grothues J, Reinhardt S, Meyer C, Hapke U, et al. The reliability and validity of the Alcohol Use Disorders Identification Test (AUDIT) in a German general practice population sample. J Stud Alcohol. May 2006; 67(3):473-481. PMID: 16608159
26. Saunders JB, Aasland OG, Babor TF, de la Fuente JR, Grant M. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption - II. Addiction. Jun 1993; 88(6):791-804. PMID: 8329970
27. Bing EG, Burnam MA, Longshore D, Fleishman JA, Sherbourne CD, London AS, et al. Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States. Arch Gen Psychiatry. 2001; 58:721-728. PMID: 11483137
28. Carver CS. You want to measure coping but your protocol's too long: consider the brief COPE. Int J Behav Med. 1997; 4(1):92-100. PMID: 16250744
29. Watt MH, Maman S, Golin CE, Earp JA, Eng E, Bangdiwala SI, et al. Factors associated with selfreported adherence to antiretroviral therapy in a Tanzanian setting. AIDS care. Mar 2010; 22(3):381-389. doi: 10.1080/09540120903193708 PMID: 20390519
30. Tsai AC, Weiser SD, Petersen ML, Ragland K, Kushel MB, Bangsberg DR. A marginal structural model to estimate the causal effect of antidepressant medication treatment on viral suppression among homeless and marginally housed persons with HIV. Arch Gen Psychiatry. Dec 2010; 67(12):1282-1290. doi: 10.1001/archgenpsychiatry.2010.160 PMID: 21135328
31. Pyne JM, Fortney JC, Curran GM, Tripathi S, Atkinson JH, Kilbourne AM, et al. Effectiveness of collaborative care for depression in human immunodeficiency virus clinics. Archives of internal medicine. Jan 10 2011; 171(1):23-31. doi: 10.1001/archinternmed.2010.395 PMID: 21220657
32. Horberg MA, Silverberg MJ, Hurley LB, Towner WJ, Klein DB, Bersoff-Matcha S, et al. Effects of depression and selective serotonin reuptake inhibitor use on adherence to highly active antiretroviral therapy and on clinical outcomes in HIV-infected patients. Journal of acquired immune deficiency syndromes (1999). Mar 1 2008; 47(3):384-390.
33. Yun LW, Maravi M, Kobayashi JS, Barton PL, Davidson AJ. Antidepressant treatment improves adherence to antiretroviral therapy among depressed HIV-infected patients. Journal of acquired immune deficiency syndromes (1999). Apr 1 2005; 38(4):432-438.
34. Primeau MM, Avellaneda V, Musselman D, Jean GS, Illa L. Treatment of Depression in Individuals Living with HIV/AIDS. Psychosomatics. Feb 1 2013.